331 related articles for article (PubMed ID: 9512119)
1. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas.
Ohashi K; Nemoto T; Eishi Y; Matsuno A; Nakamura K; Hirokawa K
Virchows Arch; 1997 May; 430(5):389-95. PubMed ID: 9174629
[TBL] [Abstract][Full Text] [Related]
3. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
5. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx.
Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A
J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027
[TBL] [Abstract][Full Text] [Related]
6. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
Yook JI; Kim J
Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cell cycle related proteins cyclin D1, p53 and p21WAF1/Cip1 in esophageal squamous cell carcinoma].
Lin DC; Shi ZZ; Xue LY; Chen W; Xu X; Han YL; Lv N; Wang MR
Yi Chuan; 2010 May; 32(5):455-60. PubMed ID: 20466633
[TBL] [Abstract][Full Text] [Related]
8. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
Villaseca M; Araya JC; Roa I; Roa JC
Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
[TBL] [Abstract][Full Text] [Related]
9. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
11. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps.
Murakami K; Mitomi H; Yamashita K; Tanabe S; Saigenji K; Okayasu I
Am J Clin Pathol; 2001 Feb; 115(2):224-34. PubMed ID: 11211611
[TBL] [Abstract][Full Text] [Related]
12. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
[TBL] [Abstract][Full Text] [Related]
13. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between p53 nuclear protein accumulation and mutations of the p53 gene in human esophageal cancer from linxian].
Liang Y; Lu S; Guo Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):412-4. PubMed ID: 8697989
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations in gastric and esophageal cancers.
Imazeki F; Omata M; Nose H; Ohto M; Isono K
Gastroenterology; 1992 Sep; 103(3):892-6. PubMed ID: 1499939
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
17. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
Werness BA; Wang HQ; Chance J; Goldstein DJ
Mod Pathol; 1997 Jun; 10(6):578-84. PubMed ID: 9195575
[TBL] [Abstract][Full Text] [Related]
18. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
20. Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
Werness BA; Jobe JS; DiCioccio RA; Piver MS
Int J Gynecol Pathol; 1997 Apr; 16(2):149-55. PubMed ID: 9100069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]